Diana Wood has been named vice president, business development for Stason Pharmaceuticals, where she will be responsible for all business development functions, including guiding the company's global business development activities. Ms. Wood is a senior executive with extensive experience in sales, marketing, business and strategic planning, product development and general management on a worldwide basis. She will report directly to chief executive officer Harry T. Fan.

Most recently, she served as the executive vice president, business development at Chiltern International, where she oversaw the company's global business development and marketing functions, and advised clients on their product development platforms. Prior to joining Chiltern, she served as the director, product development for oncology at Chugai Pharma USA.

"We are pleased to welcome Diana to Stason," said Mr. Fan. "As a seasoned business development executive, she has built a highly respected track record and earned the trust of the pharmaceutical community. Diana will be a strategically important asset to our company."